{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:29:11Z","timestamp":1789010951483,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.hoc.2023.04.013","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T08:50:37Z","timestamp":1685350237000},"page":"841-848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hereditary Renal Cell Carcinoma Syndromes"],"prefix":"10.1016","volume":"37","author":[{"given":"Maria I.","family":"Carlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hoc.2023.04.013_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","article-title":"Pathogenic germline variants in 10,389 adult cancers","volume":"173","author":"Huang","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.hoc.2023.04.013_bib2","first-page":"199","article-title":"Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I","volume":"206","author":"Campbell","year":"2021","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.hoc.2023.04.013_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","article-title":"Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Motzer","year":"2022","journal-title":"J\u00a0Natl Compr Cancer Netw JNCCN"},{"issue":"6","key":"10.1016\/j.hoc.2023.04.013_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/cge.13014","article-title":"Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers","volume":"92","author":"Muller","year":"2017","journal-title":"Clin Genet"},{"issue":"23","key":"10.1016\/j.hoc.2023.04.013_bib5","first-page":"00054","article-title":"Fumarate Hydratase Variants and their Association with Paraganglioma\/Pheochromocytoma","volume":"S0090-4295","author":"Zavoshi","year":"2023","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.hoc.2023.04.013_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.23900","article-title":"Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma","volume":"41","author":"Zhang","year":"2020","journal-title":"Hum Mutat"},{"issue":"22","key":"10.1016\/j.hoc.2023.04.013_bib7","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl7","key":"10.1016\/j.hoc.2023.04.013_bib8","first-page":"S808","article-title":"LBA69 - Belzutifan, a HIF-2\u03b1 Inhibitor, for von Hippel-Lindau (VHL) disease-associated neoplasms: 36\u00a0months of follow-up of the phase II LITESPARK-004 study","volume":"33","author":"Srinivasan","year":"2022","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2023.04.013_bib9","doi-asserted-by":"crossref","first-page":"e2132615","DOI":"10.1001\/jamanetworkopen.2021.32615","article-title":"Assessment of risk of hereditary predisposition in patients with melanoma and\/or mesothelioma and renal neoplasia","volume":"4","author":"Gupta","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.hoc.2023.04.013_bib10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamadermatol.2017.2330","article-title":"Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature","volume":"153","author":"Haugh","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.hoc.2023.04.013_bib11","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide","volume":"110","author":"Walpole","year":"2018","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.hoc.2023.04.013_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/modpathol.2014.86","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma","volume":"28","author":"Williamson","year":"2015","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2023.04.013_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","article-title":"Tumour risks and genotype\u2013phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB , SDHC and SDHD","volume":"55","author":"Andrews","year":"2018","journal-title":"J\u00a0Med Genet"},{"issue":"4","key":"10.1016\/j.hoc.2023.04.013_bib14","doi-asserted-by":"crossref","first-page":"a002584","DOI":"10.1101\/mcs.a002584","article-title":"Germline SDHA mutations in children and adults with cancer","volume":"4","author":"Dubard Gault","year":"2018","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"10","key":"10.1016\/j.hoc.2023.04.013_bib15","first-page":"12188","article-title":"A\u00a0novel germline mutation in SDHA identified in a rare case of gastrointestinal stromal tumor complicated with renal cell carcinoma","volume":"8","author":"Jiang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"10.1016\/j.hoc.2023.04.013_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.hoc.2023.04.013_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.hoc.2023.04.013_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2012.43.3383","article-title":"Phase II and Biomarker Study of the Dual MET\/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma","volume":"31","author":"Choueiri","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2023.04.013_bib19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.hoc.2023.04.013_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/cge.13875","article-title":"A\u00a0review on age-related cancer risks in PTEN hamartoma tumor syndrome","volume":"99","author":"Hendricks","year":"2021","journal-title":"Clin Genet"},{"issue":"6","key":"10.1016\/j.hoc.2023.04.013_bib21","first-page":"1990","article-title":"Germline PTEN Mutation Cowden Syndrome: An Under-Appreciated Form of Hereditary Kidney Cancer","volume":"190","author":"Shuch","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.hoc.2023.04.013_bib22","doi-asserted-by":"crossref","first-page":"1187.e1","DOI":"10.1016\/j.urology.2011.12.025","article-title":"Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome","volume":"79","author":"Mester","year":"2012","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.hoc.2023.04.013_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41525-020-00148-7","article-title":"Early-onset renal cell carcinoma in PTEN harmatoma tumour syndrome","volume":"5","author":"Kim","year":"2020","journal-title":"Npj Genomic Med"},{"key":"10.1016\/j.hoc.2023.04.013_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2020.11.024","article-title":"PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female","volume":"148","author":"Ramkumar","year":"2021","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.hoc.2023.04.013_bib25","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primer"},{"issue":"7","key":"10.1016\/j.hoc.2023.04.013_bib26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal Cell Carcinoma in Tuberous Sclerosis Complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.hoc.2023.04.013_bib27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41379-021-00971-y","article-title":"Renal cell carcinoma associated with tuberous sclerosis complex (TSC)\/mammalian target of rapamycin (MTOR) genetic alterations","volume":"35","author":"Argani","year":"2022","journal-title":"Mod Pathol"},{"issue":"7375","key":"10.1016\/j.hoc.2023.04.013_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A\u00a0SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.hoc.2023.04.013_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000443311","article-title":"The Microphthalmia-Associated Transcription Factor p.E318K Mutation Does Not Play a Major Role in Sporadic Renal Cell Tumors from Caucasian Patients","volume":"83","author":"Stoehr","year":"2016","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"},{"key":"10.1016\/j.hoc.2023.04.013_bib30","series-title":"GeneReviews\u00ae","article-title":"CDC73-Related Disorders","author":"Hyde","year":"1993"},{"issue":"4","key":"10.1016\/j.hoc.2023.04.013_bib31","first-page":"1449","article-title":"A\u00a0genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome","volume":"85","author":"Haven","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.hoc.2023.04.013_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.urology.2018.11.013","article-title":"CDC73 germline mutation in a family with mixed epithelial and stromal tumors","volume":"124","author":"Vocke","year":"2019","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.hoc.2023.04.013_bib33","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/hmg\/ddt638","article-title":"The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function","volume":"23","author":"Qin","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.hoc.2023.04.013_bib34","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/jmedgenet-2014-102912","article-title":"A\u00a0germline mutation in PBRM1 predisposes to renal cell carcinoma","volume":"52","author":"Benusiglio","year":"2015","journal-title":"J\u00a0Med Genet"},{"issue":"16","key":"10.1016\/j.hoc.2023.04.013_bib35","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/hmg\/ddac066","article-title":"Elongin C (ELOC\/TCEB1)-associated von Hippel\u2013Lindau disease","volume":"31","author":"Andreou","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.hoc.2023.04.013_bib36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.hoc.2023.04.013_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1158\/2159-8290.CD-14-1096","article-title":"Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma","volume":"5","author":"Jafri","year":"2015","journal-title":"Cancer Discov"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858823000473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858823000473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:20:22Z","timestamp":1760185222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858823000473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0889858823000473"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2023.04.013","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary Renal Cell Carcinoma Syndromes","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2023.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}